rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2008-1-15
|
pubmed:abstractText |
Botulinum toxin type A (BoNT-A) for the treatment of patients with various forms of migraine has been studied, but there is a paucity of data regarding the use of BoNT-A in Asian headache patients. Our study was designed to evaluate the efficacy of BoNT-A in the treatment of transformed migraine (TM) in a population of Taiwanese patients.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1726-4901
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
535-40
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18194894-Adult,
pubmed-meshheading:18194894-Aged,
pubmed-meshheading:18194894-Botulinum Toxins, Type A,
pubmed-meshheading:18194894-Female,
pubmed-meshheading:18194894-Headache Disorders,
pubmed-meshheading:18194894-Humans,
pubmed-meshheading:18194894-Male,
pubmed-meshheading:18194894-Middle Aged,
pubmed-meshheading:18194894-Migraine Disorders,
pubmed-meshheading:18194894-Randomized Controlled Trials as Topic,
pubmed-meshheading:18194894-Retrospective Studies
|
pubmed:year |
2007
|
pubmed:articleTitle |
Botulinum toxin type a in the prophylactic treatment of transformed migraine in Taiwanese patients: a review of 30 consecutive cases.
|
pubmed:affiliation |
Department of Neurology, Ten Chan [corrected] Hospital, Chung-Li, Taiwan, R O C.
|
pubmed:publicationType |
Journal Article
|